G-protein-coupled receptors: Turn-ons and turn-offs

Current Opinion in Neurobiology

Volumn 8, Issue 3, 1998, Pages 335-344

  Carman, Christopher V ^a   Benovic, Jeffrey L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR PROTEIN;

CELL FUNCTION; ENDOCYTOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032101983     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(98)80058-5     Document Type: Article

References (75)

1. Penn RB, Benovic JL. Mechanisms of receptor regulation. Conn PM. Handbook of Physiology: Section 7: Endocrinology, Volume I: Cellular Endocrinology. 1998;125-164 Oxford University Press, New York.
2. Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol. 38:1998;289-319.
3. Ferguson SS, Barak LS, Zhang J, Caron MG. G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can J Physiol Pharmacol. 74:1996;1095-1110.
4. Freedman NJ, Ament AS, Oppermann M, Stoffel RH, Exum ST, Lefkowitz RJ. Phosphorylation and desensitization of human endothelin A and B receptors: Evidence for G protein-coupled receptor kinase specificity. J Biol Chem. 272:1997;17734-17743.
5. Aramori I, Zhang J, Ferguson SSG, Bieniasz PD, Cullen BR, Caron MG. Molecular mechanisms of desensitization of the chemokine receptor CCR-5: Receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J. 16:1997;4606-4616.
6. Bais C, Bianca S, Coso O, Arvanitakis L, Raaka GE, Gutkind JS, Asch AJ, Cesarman E, Gerhengorn MC, Mesri EA. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. of special interest Nature. 391:1998;86-89 The Kaposi's sarcoma-associated herpesvirus (KSVH)-GPR represents a novel constitutively active GPR that promotes cell transformation and tumorigenicity through activation of JNK/SAPK and p38MAPK. In NIH-3T3 cells, KSVH-GPR-induced cell proliferation was specifically inhibited by overexpression of GRK5, suggesting a potential therapeutic avenue to be explored for such GPR-dependent tumors.
7. Oppermann M, Diverse-Pierluissi M, Drazner MH, Dyer SL, Freedman NJ, Peppel KC, Lefkowitz RJ. Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases. Proc Natl Acad Sci USA. 93:1996;7649-7654.
8. Shih M, Malbon CC. Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and beta-adrenergic receptor kinase reveal distinctive cell-type-specific roles in agonist-induced desensitization. Proc Natl Acad Sci USA. 91:1994;12193-12197.
9. Nagayama Y, Tanaka K, Hara T, Namba H, Yamashita S, Taniyama K, Niwa M. Involvement of G protein-coupled receptor kinase 5 in homologous desensitization of the thyrotropin receptor. J Biol Chem. 271:1996;10143-10148.
10. 2-adrenergic receptor. J Biol Chem. 269:1994;13084-13087.
11. 8-coupled receptors, that of secretin and IP-prostanoid, were unaffected by overexpression of GRK2-K220R.
12. Fukayama S, Kong G, Benovic JL, Meurer E, Tashjian AH Jr. β-Adrenergic receptor kinase-1 acutely regulates PTH/PTHrP receptor signalling in human osteoblast-like cells. Cell Signaling. 9:1997;469-474.
13. Koch WJ, Rockman HA, Samana P, Hamilton R, Bond RA, Milano CA, Letkowitz RJ. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science. 268:1995;1350-1353.
14. Rockman HA, Choi DJ, Rahman NU, Akhter SA, Lefkowitz RJ, Koch WJ. Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc Natl Acad Sci USA. 93:1996;9954-9959.
15. Iaccarino G, Shotwell KF, Rockman HA, Koch WJ. Lack of desensitization of the cardiac β-adrenergic system in βARK2 overexpressing transgenic mice [abstract]. Circulation. 96:1997;1-293.
16. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, Sulik KK, Ross J Jr, Lefkowitz RJ, Caron MG, Giros B. Essential role of β-adrenergic receptor kinase in cardiac development and function. of special interest Proc Natl Acad Sci USA. 93:1996;12974-12979 The GRK2 gene was disrupted by homologous recombination in mice leading to embryonic death at around day 15 attributed to severe hypoplasia of the ventricular myocardium. This phenotype is interestingly similar to that of 'thin myocardial syndrome' which is associated with disruption of several transcription factors (RXRα, N-Myc, TEF-1, WT-1). This study demonstrates an important role for GRK2 in development.
17. of special interest Schneider LE, Spradling AC. The Drosophila G protein-coupled receptor kinase homologue Gprk2 is required for egg morphogenesis. Development. 124:1997;2591-2602 A mutation in Drosophila Gprk2 (a GRK4 subfamily homolog) was identified and shown to disrupt expression of Gprk2 in the central nervous system and ovaries of females, rendering them sterile. However, rare eggs that did become fertilized displayed gross defects in embryogenesis, primarily associated with anterior chorion formation, suggesting a role for GRKs in regulation of growth and development.
18. Peppel K, Boekhoff I, McDonald P, Breer H, Caron MG, Lefkowitz RJ. G protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization. of special interest J Biol Chem. 272:1997;25425-25428 Targeted gene disruption was performed to produce GRK-3 deficient mice which were normal in embryonic and postnatal development. However, cilia preparations from the olfactory epithelium, which normally express an abundance of GRK3 but not GRK2, were obtained from the GRK3-deficient mice and shown to lack the fast agonist-induced desensitization seen after odorant stimulation in cilia from wild-type mice.
19. Dolph PJ, Ranganathan R, Colley NJ, Hardy RW, Socolich M, Zuker CS. Arrestin function in inactivation of G-protein-coupled receptor rhodopsin in vivo. Science. 260:1993;1910-1916.
20. Xu J, Dodd RL, Makino CL, Simon MI, Baylor DA, Chen J. Prolonged photoresponses in transgenic mouse rods lacking arrestin. of special interest Nature. 389:1997;505-509 Rod cells were isolated from arrestin-deficient mice, generated by targeted gene disruption, allowing measurement of single-cell photoresponses. These experiments revealed that the initial kinetics of recovery, probably governed by rhodopsin kinase, were normal while the final phase of recovery was significantly prolonged in the absence of functional arrestin.
21. Stoffel RH 3rd, Pitcher JA, Lefkowitz RJ. Targeting G protein-coupled receptor kinases to their receptor substrates. J Membr Biol. 157:1997;1-8.
22. Daaka Y, Pitcher JA, Richardson M, Stoffel RH, Robishaw JD, Lefkowitz RJ. Receptor and Gβγ isoform-specific interactions with G protein-coupled receptors. Proc Natl Acad Sci USA. 94:1996;2180-2185.
23. Wu G, Benovic JL, Hildebrandt JD, Lanier SM. Intracellular motifs of G-protein coupled receptors present docking sites for G-protein βγ subunits. of special interest J Biol Chem. 273:1998;7197-7200 GRK2-mediated binding and phosphorylation of purified GST - m2AChR and - m3AChR third intracellular loop fusion proteins was examined in the absence and presence of G-protein βγ subunits. These experiments demonstrate βγ-dependent enhancement of both binding and phosphorylation suggesting that βγ may directly target GRK2 to receptor substrates via formation of a GPR/GRK2/βγ ternary complex.
24. Ruiz-Gomez A, Mayor F Jr. β-adrenergic receptor kinase (GRK2) colocalizes with β-adrenergic recetors during agonist-induced receptor internalization. J Biol Chem. 272:1997;9601-9604.
25. Deburman SK, Ptasienski J, Benovic JL, Hosey MM. G protein-coupled receptor kinase GRK2 is a phospholipid-enzyme that can be conditionally activated by G protein βγ subunits. J Biol Chem. 271:1996;22552-22562.
26. Touhara K. Binding of multiple ligands to pleckstrin homology domain regulates membrane translocation and enzyme activity of β-adrenergic receptor kinase. FEBS Lett. 417:1997;243-248.
27. βγ subunits. J Biol Chem. 273:1998;2835-2843.
28. 2 binding site distinguishes the GRK subfamilies. J Biol Chem. 271:1996;24907-24913.
29. Klenchin VA, Calvert PD, Bownds MD. Inhibition of rhodopsin kinase by recoverin: Further evidence for a negative feedback system in phototransduction. J Biol Chem. 270:1995;16147-16152.
30. Wistel R, Freund S, Krasel C, Hoppe E, Lohse MJ. Protein kinase cross-talk: Membrane targeting of the β-adrenergic receptor kinase by protein kinase C. Proc Natl Acad Sci USA. 93:1995;2105-2109.
31. Chuang TT, LeVine H III, De Blasi A. Phosphorylation and activation of β-adrenergic receptor kinase by protein kinase C. J Biol Chem. 270:1995;18660-18665.
32. Pronin AN, Benovic JL. Regulation of the G protein-coupled receptor kinase GRK5 by protein kinase C. J Biol Chem. 272:1997;3806-3812.
33. 2+/calmodulin. J Biol Chem. 271:1996;28691-28696.
34. 2-binding domain (amino acids 22-29) previously described by Pitcher et al., 1996 [28].
35. 2-adrenergic receptors. J Biol Chem. 272:1997;17836-17842.
36. 2ARs and m2AChRs reveals that these GPRs bind agonists (but not antagonists) with higher affinity when complexed with an arrestin. These studies also demonstrate selectivity among various arrestins and receptors with respect to this phenomenon, which may reflect receptor- and arrestin-dependent differences in the propensity of arrestins to undergo transition into the active receptor-binding state.
37. Barak LS, Ferguson SSG, Zhang J, Caron MG. A β-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. of special interest J Biol Chem. 272:1997;27497-27500 To investigate cellular GPR - arrestin interaction, an arrestin-3-GFP construct, GRK2, and various GPRs were co-transfected into HEK-293 and COS-7 cells. This system provides 'real-time' visualization of the dynamic recruitment of cytosolic arrestin-3 to the plasma membrane upon receptor activation and illuminates the critical role of GRKs in supporting this process. Importantly, arrestin-3 mobilization was shown to be elicited by activation of 15 distinct GPRs, suggesting the 'universality' of this regulatory process.
38. Krupnick JG, Gurevich VV, Benovic JL. Mechanism of quenching phototransduction: Binding competition between arrestin and transducin for phosphorhodopsin. J Biol Chem. 272:1997;18125-18131.
39. Zhang L, Sports CD, Osawa S, Weiss ER. Rhodopsin phosphorylation sites and their role in arrestin binding. J Biol Chem. 272:1997;14762-14768.
40. Gurevich VV, Benovic JL. Visual arrestin binding to rhodopsin: Diverse functional roles of positively charged residues within the phosphorylation-recognition region of arrestin. J Biol Chem. 270:1995;6010-6016.
41. Gurevich VV, Benovic JL. Mechanism of phosphorylation-recognition by visual arrestin and the transition of arrestin into a high affinity binding state. of special interest Mol Pharmacol. 51:1997;161-169 The critical phosphorylation-recognition residue Arg175, as well as adjacent conserved hydrophobic residues in arrestin were extensively mutagenized and then assessed for their ability to bind phosphorylated, light-activated rhodopsin as well as phosphorylation-site-deficient rhodopsin. These studies reveal two relatively independent changes that occur in arrestin on receptor binding: increased binding affinity of the phosphorylation-recognition region for the phosphorylated carboxyl-termianl tail of rhodopsin; and mobilization of additional receptor-binding sites. These experiments also reveal that charge inversion at position 175 generates a 'constitutively active' arrestin that demonstrates phosphorylation-independent receptor binding.
42. Granzin J, Wilden U, Choe H-W, Labahn J, Krafft B, Büldt G. X-ray crystal structure of arrestin from bovine rod outer segments. Nature. 391:1998;918-921.
43. Tsuga H, Kameyama K, Haga T, Kurose H, Nagao T. Sequestration of muscarinic acetylcholine receptor m2 subtypes: Facilitation by G protein-coupled receptor kinase (GRK2) and attenuation by a dominant-negative mutant of GRK2. J Biol Chem. 269:1994;32522-32527.
44. Ferguson SSG, Ménard L, Barak LS, Koch WJ, Colapietro AM, Caron MG. Role of phsophorylation in agonist-promoted β-adrenergic receptor sequestration. J Biol Chem. 270:1995;24782-24789.
45. 2-adrenergic receptor facilitate sequestration. Biochemistry. 35:1996;4155-4160.
46. 2AR inhibited its sequestration, demonstrating a functional role for arrestins in receptor internalization.
47. 2-adrenergic receptor sequestration: Intracellular complement of β-adrenergic receptor kinase and β-arrestin determine kinetics of internalization. Mol Pharmacol. 51:1997;800-808.
48. Schlador ML, Nathanson NM. Synergistic regulation of m2 muscarinic acetylcholine receptor desensitization and sequestration by G protein-coupled receptor kinase-2 and β-arrestin-1. of special interest J Biol Chem. 272:1997;18882-18890 Overexpression of GRK2 and β-arrestin together in JEG-3 cells synergistically enhanced both the rate and extent of agonist-induced m2AChR sequestration. These studies highlight the potential for dramatic functional effects of GRK and arrestin composition in cells on the regulation of GPRs.
49. Zhang J, Ferguson SSG, Barak LS, Ménard L, Caron MG. Dynamin and β-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization. J Biol Chem. 271:1996;18302-18305.
50. Pals-Rylaarsdam R, Gurevich VV, Lee KB, Ptasienski JA, Benovic JL, Hosey MM. Internalization of the m2 muscarinic acetylcholine receptor: Arrestin-independent and -dependent pathways. J Biol Chem. 272:1997;23682-23689.
51. 2ARs were shown through immunofluorescence microscopy to co-localize with β-arrestin and clathrin in an agonist-dependent fashion. Collectively, these experiments demonstrate that non-visual arrestins serve as clathrin adaptors for GPR endocytosis.
52. Krupnick JG, Goodman OB Jr, Keen JH, Benovic JL. Arrestin/clathrin interaction: Localization of the clathrin binding domain of nonvisual arrestins to the carboxyl terminus. J Biol Chem. 272:1997;15011-15016.
53. Goodman OB Jr, Krupnick JG, Gurevich VV, Benovic JL, Keen JH. Arrestin/clathrin interaction: Localization of the arrestin binding locus to the clathrin terminal domain. J Biol Chem. 272:1997;15017-15022.
54. 2AR internalization.
55. i, with or without β-agonist pretreatment. This revealed constitutive phosphorylation of Ser412 on β-arrestin, as well as agonist-dependent and membrane-localized β-arrestin dephosphorylation. It was demonstrated that the phosphorylated arrestin, as well as a β-arrestin-S412D mutant were competent for receptor binding and desensitization but unable to bind clathrin and promote receptor sequestration, suggesting a possible role for phosphorylation in modulating arrestin activity.
56. 2ARs in HEK-293 cells. These studies suggest a model for the regulation of resensitization whereby endosomal acidification may promote a receptor conformational change required for interaction with phosphatase.
57. 2AR were stimulated by arrestin-3 overexpression, suggesting that arrestin-dependent sequestration is required for GPR resensitization.
58. Vinos J, Jalink K, Hardy RW, Britt SG, Zuker CS. A G protein-coupled receptor phosphatase required for rhodopsin function. of special interest Science. 277:1997;687-690 A previously identified mutation in the Drosophila rhodopsin phosphatase was examined biochemically and physiologically, revealing severe defects in phototransduction as well as a light-dependent retinal degeneration attributed to an accumulation of hyperphosphorylated rhodopsin. These studies highlight the physiological importance of both rhodopsin phosphorylation and dephosphorylation activities in the visual system.
59. 2-adrenergic receptor. J Biol Chem. 273:1998;322-328.
60. 2ARs whereas these processes were profoundly and modestly inhibited by overexpression of dynamin-K44A and a β-arrestin(319-418) respectively, demonstrating a direct link between sequestration and downregulation mechanisms in these cells. Interestingly, similar experiments in COS-1 and HeLa cells revealed qualitatively similar but quantitatively distinct relationships between sequestration and downregulation, underscoring the importance of cellular components in these processes.
61. Hicke L, Riezman H. Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis. Cell. 84:1996;277-287.
62. Luttrell LM, Daaka Y, Della Rocca GJ, Lefkowitz RJ. G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in Rat 1a fibroblasts: Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases. of outstanding interest J Biol Chem. 272:1997;31648-31656 Whereas LPA, thrombin and EGF receptor stimulation in rat 1a fibroblasts and HEK-293 cells resulted in rapid Shc phosphorylation followed by ERK phosphorylation and activation, inhibition of clathrin-mediated endocytosis with either concanavalin A, hypertonic medium, depletion of intracellular potassium or monodansylcadaverine blocked ERK activation. Thus, these studies propose that in addition to tyrosine phosphorylation-dependent assembly of signalling complexes at the plasma membrane, internalization through clathrin-mediated endocytosis is required for the distal steps in the MAPK signalling cascade.
63. Daaka Y, Luttrell LM, Ahn S, Della Rocca GJ, Ferguson SSG, Caron MG, Lefkowitz RJ. Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase. J Biol Chem. 273:1998;685-688.
64. Lohse MJ, Engelhardt S, Danner S, Bohm M. Mechanisms of β-adrenergic receptor desensitization: From molecular biology to heart failure. Basic Res Cardiol. 91:1996;29-34.
65. Ping P, Anzai T, Gao M, Hammond HK. Adenylyl cyclase and G protein receptor kinase expression during development of heart failure. Am J Physiol. 273:1997;H707-H717.
66. Choi DJ, Koch WJ, Hunter JJ, Rockman HA. Mechanism of β-adrenergic receptor desensitization in cardiac hypertrophy is increased β-adrenergic receptor kinase. of special interest J Biol Chem. 272:1997;17223-17229 Pressure overload-induced cardiac hypertrophy was achieved following 7 days of transverse aortic constriction in mice and was associated with marked βAR desensitization as well as an approximately threefold increase in βARK activity and increased βARK expression. Introduction of both GRK-specific antibodies and a βARK inhibitor polypeptide prevented βAR desensitization in vitro and in vivo, respectively, demonstrating that the enhanced βARK activity was largely responsible for the observed alteration in βAR signalling.
67. Ungerer M, Kessebohm K, Kronsbein K, Lohse MJ, Richardt G. Activation of β-receptor kinase during myocardial infarction. Circ Res. 79:1996;455-460.
68. Iaccarino G, Lefkowitz RJ, Koch WJ. Reciprocal regulation of myocardial βARK1 by β-adrenergic agonists and antagonists [abstract]. Circulation. 96:1997;1-495.
69. Ishizaka N, Alexander RW, Laursen JB, Kai H, Fukui T, Oppermann M, Lefkowitz RJ, Griendling KK. G protein-coupled receptor kinase 5 in cultured vascular smooth muscle cells and rat aorta: regulation by angiotensin II and hypertension. J Biol Chem. 272:1997;32482-32488.
70. Gros R, Benovic JL, Tan CM, Feldman RD. G protein-coupled receptor kinase activity is increased in hypertension. of special interest J Clin Invest. 99:1997;2060-2061 GRK activity and expression was assessed by rhodopsin phosphorylation and immunoblotting, respectively, in lymphocytes of both hypertensive and normotensive subjects. These studies reveal increased GRK activity and a selective increase in GRK2 expression that may underlie the reduce β-adrenergic responsiveness characteristic of the hypertensive state.
71. Akhter SA, Skaer CA, Kypson AP, McDonald PH, Peppel KC, Glower DD, Lefkowitz RJ, Koch RJ. Restoration of β-adrenergic signaling in falling cardiac ventricular myocytes via adenoviral-mediated gene transfer. of special interest Proc Natl Acad Sci USA. 94:1997;12100-12105 Rabbits with tachycardia-induced CHF were shown to exhibit a physiological reduction in myocardial function characteristic of CHF, as well as decreased βAR signalling (~twofold), increased GRK2 expression (~twofold) and increased GRK activity (~threefold). Adenovirus-mediated expression of a GRK2 minigene inhibitor in cultured left ventricular myocytes from failing hearts restored βAR-mediated cAMP production to levels equal to or greater than those of control myocytes, demonstrating that the reduced βAR signalling is attributable to increased GRK2 activity.
72. Farber D, Danciger M. Identification of genes causing photoreceptor degenerations leading to blindness. Curr Opin Neurobiol. 7:1997;666-673.
73. Nakazawa M, Wada Y, Fuchs S, Gal A, Tamai M. Oguchi disease: Phenotypic characteristics of patients with frequent 1147delA mutation in the arrestin gene. Retina. 17:1997;17-22.
74. Yamamoto S, Sippel KC, Berson EL, Dryja TP. Defects in the rhodopsin kinase gene in Oguchi form of stationary night blindness. Nat Genet. 15:1997;175-178.
75. Cidecyan AV, Zhao X, Neilsen L, Khani SC, Jacobson SG, Palczewski K. Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. of special interest Proc Natl Acad Sci USA. 95:1998;328-333 Electroretinography and psychophysics were used to measure in vivo photoresponses in an Oguchi patient shown to be homozygous for a rhodopsin kinase deletion thought to generate a null phenotype. These data demonstrate rod recovery phase abnormalities that interestingly slowed both rod and cone deactivation kinetics.